Cov-MS: a community-based template assay for clinical MS-based protein detection in SARS-CoV-2 patients
View ORCID ProfileB. Van Puyvelde, View ORCID ProfileK. Van Uytfanghe, View ORCID ProfileO. Tytgat, L. Van Oudenhove, View ORCID ProfileR. Gabriels, View ORCID ProfileR. Bouwmeester, View ORCID ProfileS. Daled, T. Van Den Bossche, View ORCID ProfileP. Ramasamy, View ORCID ProfileS. Verhelst, View ORCID ProfileL. De Clerck, View ORCID ProfileL. Corveleyn, View ORCID ProfileN. Debunne, View ORCID ProfileE. Wynendaele, View ORCID ProfileB. De Spiegeleer, P. Judak, K. Roels, View ORCID ProfileL. De Wilde, P. Van Eenoo, T. Reyns, View ORCID ProfileM. Cherlet, E. Dumont, View ORCID ProfileG. Debyser, R. t’Kindt, K. Sandra, View ORCID ProfileS. Gupta, View ORCID ProfileNicolas Drouin, View ORCID ProfileAmy Harms, View ORCID ProfileThomas Hankemeier, View ORCID ProfileDJL Jones, P. Gupta, D. Lane, View ORCID ProfileC.S. Lane, S. El Ouadi, JB. Vincendet, N. Morrice, S. Oehrle, N. Tanna, S. Silvester, S. Hannam, View ORCID ProfileF. Sigloch, A. Bhangu-Uhlmann, View ORCID ProfileJ. Claereboudt, L. Anderson, M. Razavi, View ORCID ProfileS. Degroeve, View ORCID ProfileL. Cuypers, View ORCID ProfileC. Stove, View ORCID ProfileK. Lagrou, G. Martens, View ORCID ProfileD. Deforce, View ORCID ProfileL. Martens, View ORCID ProfileJ.P.C. Vissers, View ORCID ProfileM. Dhaenens
doi: https://doi.org/10.1101/2020.11.18.20231688
B. Van Puyvelde
1ProGenTomics, Laboratory of Pharmaceutical Biotechnology, Ghent University, Ghent, Belgium
K. Van Uytfanghe
2Laboratory of Toxicology, Department of Bioanalysis, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium
O. Tytgat
1ProGenTomics, Laboratory of Pharmaceutical Biotechnology, Ghent University, Ghent, Belgium
9Department of Life Science Technologies, Imec, Leuven, Belgium
L. Van Oudenhove
3Waters Corporation, Antwerp, Belgium
R. Gabriels
4VIB-UGent Center for Medical Biotechnology, VIB, Ghent, Belgium
5Department of Biomolecular Medicine, Ghent University, Ghent Belgium
R. Bouwmeester
4VIB-UGent Center for Medical Biotechnology, VIB, Ghent, Belgium
5Department of Biomolecular Medicine, Ghent University, Ghent Belgium
S. Daled
1ProGenTomics, Laboratory of Pharmaceutical Biotechnology, Ghent University, Ghent, Belgium
T. Van Den Bossche
4VIB-UGent Center for Medical Biotechnology, VIB, Ghent, Belgium
5Department of Biomolecular Medicine, Ghent University, Ghent Belgium
P. Ramasamy
4VIB-UGent Center for Medical Biotechnology, VIB, Ghent, Belgium
5Department of Biomolecular Medicine, Ghent University, Ghent Belgium
16Interuniversity Institute of Bioinformatics in Brussels, ULB/VUB, Brussels, Belgium
S. Verhelst
1ProGenTomics, Laboratory of Pharmaceutical Biotechnology, Ghent University, Ghent, Belgium
L. De Clerck
1ProGenTomics, Laboratory of Pharmaceutical Biotechnology, Ghent University, Ghent, Belgium
L. Corveleyn
1ProGenTomics, Laboratory of Pharmaceutical Biotechnology, Ghent University, Ghent, Belgium
N. Debunne
21Drug Quality and Registration Group, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium
E. Wynendaele
21Drug Quality and Registration Group, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium
B. De Spiegeleer
21Drug Quality and Registration Group, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium
P. Judak
11Doping Control Laboratory, Department of Diagnostic Sciences, Ghent University, Ghent, Belgium
K. Roels
11Doping Control Laboratory, Department of Diagnostic Sciences, Ghent University, Ghent, Belgium
L. De Wilde
11Doping Control Laboratory, Department of Diagnostic Sciences, Ghent University, Ghent, Belgium
P. Van Eenoo
11Doping Control Laboratory, Department of Diagnostic Sciences, Ghent University, Ghent, Belgium
T. Reyns
12Department of Clinical Chemistry, Ghent University Hospital, Ghent, Belgium
M. Cherlet
17Department of Pharmacology, Toxicology, and Biochemistry, Faculty of Veterinary Medicine, Ghent University, Belgium
E. Dumont
18Research Institute for Chromatography (RIC), Kortrijk, Belgium
G. Debyser
18Research Institute for Chromatography (RIC), Kortrijk, Belgium
R. t’Kindt
18Research Institute for Chromatography (RIC), Kortrijk, Belgium
K. Sandra
18Research Institute for Chromatography (RIC), Kortrijk, Belgium
S. Gupta
4VIB-UGent Center for Medical Biotechnology, VIB, Ghent, Belgium
5Department of Biomolecular Medicine, Ghent University, Ghent Belgium
Nicolas Drouin
19Division of Systems Biomedicine and Pharmacology, Leiden Academic Centre for Drug Research, Leiden University, 2311 G Leiden, The Netherlands
Amy Harms
19Division of Systems Biomedicine and Pharmacology, Leiden Academic Centre for Drug Research, Leiden University, 2311 G Leiden, The Netherlands
Thomas Hankemeier
19Division of Systems Biomedicine and Pharmacology, Leiden Academic Centre for Drug Research, Leiden University, 2311 G Leiden, The Netherlands
DJL Jones
13Leicester Cancer Research Centre, RKCSB, University of Leicester, UK and John and Lucille van Geest biomarker facility, Cardiovascular Research Centre, Glenfield Hospital, Leicester, UK
P. Gupta
14The Department of Chemical Pathology and Metabolic Diseases, Level 4, Sandringham Building, Leicester Royal Infirmary, Leicester, United Kingdom
D. Lane
14The Department of Chemical Pathology and Metabolic Diseases, Level 4, Sandringham Building, Leicester Royal Infirmary, Leicester, United Kingdom
C.S. Lane
10Sciex, Macclesfield, UK
S. El Ouadi
10Sciex, Macclesfield, UK
JB. Vincendet
10Sciex, Macclesfield, UK
N. Morrice
10Sciex, Macclesfield, UK
S. Oehrle
20Waters Corporation, Milford, MA / Waters Corporation, Wilmslow, UK
N. Tanna
20Waters Corporation, Milford, MA / Waters Corporation, Wilmslow, UK
S. Silvester
15Alderley Analytical, Macclesfield, UK
S. Hannam
15Alderley Analytical, Macclesfield, UK
F. Sigloch
6Polyquant GmbH, Bad Abbach, Germany
A. Bhangu-Uhlmann
6Polyquant GmbH, Bad Abbach, Germany
J. Claereboudt
3Waters Corporation, Antwerp, Belgium
L. Anderson
22SISCAPA Assay Technologies, Inc., Washington DC USA and Victoria BC Canada
M. Razavi
22SISCAPA Assay Technologies, Inc., Washington DC USA and Victoria BC Canada
S. Degroeve
4VIB-UGent Center for Medical Biotechnology, VIB, Ghent, Belgium
5Department of Biomolecular Medicine, Ghent University, Ghent Belgium
L. Cuypers
7Clinical Department of Laboratory Medicine, UZ Leuven, KU Leuven, Leuven, Belgium
C. Stove
2Laboratory of Toxicology, Department of Bioanalysis, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium
K. Lagrou
7Clinical Department of Laboratory Medicine, UZ Leuven, KU Leuven, Leuven, Belgium
G. Martens
8AZ Delta Medical Laboratories, AZ Delta General Hospital, Roeselare, Belgium
D. Deforce
1ProGenTomics, Laboratory of Pharmaceutical Biotechnology, Ghent University, Ghent, Belgium
L. Martens
4VIB-UGent Center for Medical Biotechnology, VIB, Ghent, Belgium
5Department of Biomolecular Medicine, Ghent University, Ghent Belgium
J.P.C. Vissers
20Waters Corporation, Milford, MA / Waters Corporation, Wilmslow, UK
M. Dhaenens
1ProGenTomics, Laboratory of Pharmaceutical Biotechnology, Ghent University, Ghent, Belgium
- Detailed Methods Section[supplements/231688_file07.pdf]
Posted November 20, 2020.
Cov-MS: a community-based template assay for clinical MS-based protein detection in SARS-CoV-2 patients
B. Van Puyvelde, K. Van Uytfanghe, O. Tytgat, L. Van Oudenhove, R. Gabriels, R. Bouwmeester, S. Daled, T. Van Den Bossche, P. Ramasamy, S. Verhelst, L. De Clerck, L. Corveleyn, N. Debunne, E. Wynendaele, B. De Spiegeleer, P. Judak, K. Roels, L. De Wilde, P. Van Eenoo, T. Reyns, M. Cherlet, E. Dumont, G. Debyser, R. t’Kindt, K. Sandra, S. Gupta, Nicolas Drouin, Amy Harms, Thomas Hankemeier, DJL Jones, P. Gupta, D. Lane, C.S. Lane, S. El Ouadi, JB. Vincendet, N. Morrice, S. Oehrle, N. Tanna, S. Silvester, S. Hannam, F. Sigloch, A. Bhangu-Uhlmann, J. Claereboudt, L. Anderson, M. Razavi, S. Degroeve, L. Cuypers, C. Stove, K. Lagrou, G. Martens, D. Deforce, L. Martens, J.P.C. Vissers, M. Dhaenens
medRxiv 2020.11.18.20231688; doi: https://doi.org/10.1101/2020.11.18.20231688
Cov-MS: a community-based template assay for clinical MS-based protein detection in SARS-CoV-2 patients
B. Van Puyvelde, K. Van Uytfanghe, O. Tytgat, L. Van Oudenhove, R. Gabriels, R. Bouwmeester, S. Daled, T. Van Den Bossche, P. Ramasamy, S. Verhelst, L. De Clerck, L. Corveleyn, N. Debunne, E. Wynendaele, B. De Spiegeleer, P. Judak, K. Roels, L. De Wilde, P. Van Eenoo, T. Reyns, M. Cherlet, E. Dumont, G. Debyser, R. t’Kindt, K. Sandra, S. Gupta, Nicolas Drouin, Amy Harms, Thomas Hankemeier, DJL Jones, P. Gupta, D. Lane, C.S. Lane, S. El Ouadi, JB. Vincendet, N. Morrice, S. Oehrle, N. Tanna, S. Silvester, S. Hannam, F. Sigloch, A. Bhangu-Uhlmann, J. Claereboudt, L. Anderson, M. Razavi, S. Degroeve, L. Cuypers, C. Stove, K. Lagrou, G. Martens, D. Deforce, L. Martens, J.P.C. Vissers, M. Dhaenens
medRxiv 2020.11.18.20231688; doi: https://doi.org/10.1101/2020.11.18.20231688
Subject Area
Subject Areas
- Addiction Medicine (383)
- Allergy and Immunology (699)
- Anesthesia (192)
- Cardiovascular Medicine (2853)
- Dermatology (244)
- Emergency Medicine (430)
- Epidemiology (12561)
- Forensic Medicine (10)
- Gastroenterology (806)
- Genetic and Genomic Medicine (4434)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2850)
- Health Policy (1049)
- Hematology (375)
- HIV/AIDS (893)
- Medical Education (413)
- Medical Ethics (114)
- Nephrology (462)
- Neurology (4194)
- Nursing (222)
- Nutrition (617)
- Oncology (2204)
- Ophthalmology (624)
- Orthopedics (254)
- Otolaryngology (318)
- Pain Medicine (268)
- Palliative Medicine (82)
- Pathology (486)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6783)
- Radiology and Imaging (1490)
- Respiratory Medicine (900)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)